G. Guo

Prospective swallowing outcomes after IMRT for oropharyngeal cancer: Dosimetric correlations in a population-based cohort.

S. Loewen, H. Quon, C. Myers, 2016, Oral oncology.

Prostate MRI from Radiation Oncology Perspective

G. Guo, 2020 .

VMAT partial arc technique decreases dose to organs at risk in whole pelvic radiotherapy for prostate cancer when compared to full arc VMAT and IMRT.

C. Njeh, C. DesRosiers, Ke-Chun Huang, 2022, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study.

G. Rosner, D. Lamm, E. Plimack, 2023, European urology.

MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2

C. Peng, Henan Zhao, S. Cui, 2016, Oncotarget.

Synchronous detection of miRNAs, their targets and downstream proteins in transferred FFPE sections: applications in clinical and basic research.

Yanchun Ding, Henan Zhao, S. Cui, 2012, Methods.

Expression of miR-136 is associated with the primary cisplatin resistance of human epithelial ovarian cancer.

Henan Zhao, S. Cui, Ji-yong Jiang, 2015, Oncology reports.

MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinoma

Dan Han, S. Cui, Jinyao Zhao, 2013, Tumor Biology.

Profile of differentially expressed miRNAs in high-grade serous carcinoma and clear cell ovarian carcinoma, and the expression of miR-510 in ovarian carcinoma

Jinyao Zhao, XINCHEN ZHANG, GORDON GUO, 2015, Molecular medicine reports.